Suchergebnisse - "Strauss, William E"

PubPharm (33)

1

Intravenous Iron-Induced Hypophosphatemia : An Emerging Syndrome

enthalten in: Advances in therapy | 2021

von Glaspy, J. | Wolf, M. | Strauss, W.

2

Intravenous Iron-Induced Hypophosphatemia: An Emerging Syndrome

enthalten in: Advances in therapy | 2021

von Glaspy, J. | Wolf, M. | Strauss, W.

3

Intravenous Iron-Induced Hypophosphatemia: An Emerging Syndrome

enthalten in: Advances in therapy | 2021

von Glaspy, J. | Wolf, M. | Strauss, W.

4

Intravenous Iron-Induced Hypophosphatemia: An Emerging Syndrome

enthalten in: Advances in therapy | 2021

von Glaspy, J. | Wolf, M. | Strauss, W.

5

Hypophosphatemia Associated with Intravenous Iron Therapies for Iron Deficiency Anemia : A Systematic Literature Review

enthalten in: Therapeutics and clinical risk management | 2020

von Glaspy, J. | Lim-Watson, M. | Libre, M. | +5

6

Ferumoxytol for iron deficiency anemia in patients undergoing hemodialysis. The FACT randomized controlled trial 

enthalten in: Clinical nephrology | 2019

von Macdougall, I. | Strauss, W. | Dahl, N. | +2

7

A response by Strauss et al. to "a comment on the comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia"

enthalten in: American journal of hematology | 2018

von Strauss, W. | Franklin Adkinson, N. | Macdougall, I. | +4

CommentOn: Am J Hematol. 2018 May;93(5):683-690. - PMID 29417614

8

Comparative safety of intravenous ferumoxytol versus ferric carboxymaltose in iron deficiency anemia : A randomized trial

enthalten in: American journal of hematology | 2018

von Adkinson, N. | Strauss, W. | Macdougall, I. | +5

CommentIn: Am J Hematol. 2018 Sep;93(9):E231-E232. - PMID 29981266

9

Correction to : The Ferumoxytol for Anemia of CKD Trial (FACT)-a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale

enthalten in: BMC nephrology | 2018

von Macdougall, I. | Dahl, N. | Bernard, K. | +3

ErratumFor: BMC Nephrol. 2017 Apr 3;18(1):117. - PMID 28372549

10

Correction to: The Ferumoxytol for Anemia of CKD Trial (FACT)—a randomized controlled trial of repeated doses of ferumoxytol or iron sucrose in patients on hemodialysis: background and rationale

enthalten in: BMC nephrology | 2018

von Macdougall, I. | Dahl, N. | Bernard, K. | +3